Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
For Muslim consumers, ensure the product carries a valid JAKIM Halal certification
At the end of 40 or 42 weeks (study time varied by trial), urine albumin-to-creatinine ratio (UACR) was significantly reduced among participants assigned to tirzepatide 5, 10, or 15 mg as compared with those assigned to all pooled comparators (placebo, semaglutide, insulin degludec, and insulin glargine) with adjusted mean percent changes of 19.3% [95% CI 12.525.5%], 22.0% [95% CI 15.328.1%], and 26.3% [95% CI 20.032.0%], respectively, with a greater reduction observed in participants with a UACR 30 mg/g at baseline [96]
Theochari CA, Michalopoulos G, Oikonomou EK, Giannopoulos S, Doulamis IP, Villela MA, et al
Partnered with FDA Regulated 503b Pharmacies and State Inspected 503a Pharmacies in the USA
Tirzepatide also showed outstanding effects in weight loss
